Dr Lal Pathlabs Ltd News
No rerating yet for diagnostic players despite price hikes as margins fall
While discounts have come down, pricing gap still large between incumbents and new players
 "No rerating yet for diagnostic players despite price hikes as margins fall")
Updated On : 27 Mar 2023 | 4:30 PM IST
Healthcare stocks rally up to 8% as Covid cases spurt in China, Japan
Reports suggest that Union Health Minister Mansukh Mandaviya will review the Covid-19 pandemic situation, in view of a spurt in COVID-19 cases in Japan, South Korea, Brazil, China and the US.
Updated On : 21 Dec 2022 | 11:31 AM IST
Multiple headwinds could act as margin tourniquet for diagnostics
Competitive pressures, valuations cap gains from current levels
Updated On : 21 Nov 2022 | 6:10 AM IST
